Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement:: hematological, nephrological, and otological studies of heterozygous KO mice

被引:47
作者
Matsushita, T [1 ]
Hayashi, H
Kunishima, S
Hayashi, M
Ikejiri, M
Takeshita, K
Yuzawa, Y
Adachi, T
Hirashimi, K
Sone, M
Yamamoto, K
Takagi, A
Katsumi, A
Kawai, K
Nezu, T
Takahashi, M
Nakashima, T
Naoe, T
Kojima, T
Saito, H
机构
[1] Nagoya Univ, Grad Sch Med, Dept Hematol, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Internal Med, Dept Clin Immunol, Nagoya, Aichi, Japan
[5] Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Nagoya, Aichi, Japan
[6] Nagoya Med Ctr, Clin Res Ctr, Dept Hemostasis & Thrombosis, Nagoya, Aichi, Japan
[7] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan
[8] Nagoya Univ, Grad Sch Med, Div Mol Pathol, Ctr Neural Dis & Canc, Nagoya, Aichi, Japan
[9] Nagoya Natl Hosp, Nagoya, Aichi, Japan
基金
日本学术振兴会;
关键词
May-Hegglin anomaly; Sebastian syndrome; Fechtner syndrome; Epstein syndrome; MYH9; targeted gene disruption; knockout mouse; thrombocytopenia; platelet; neutrophil;
D O I
10.1016/j.bbrc.2004.10.147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Among three different isoforms of non-muscle myosin heavy chains (NMMHCs), only NMMHCA is associated with inherited human disease, called MYH9 disorders, characterized by macrothrombocytopenia and characteristic granulocyte inclusions. Here targeted gene disruption was performed to understand fundamental as well as pathological role of the gene for NMMHCA, MYH9. Heterozygous intercrosses yielded no homozygous animals among 552 births, suggesting that MYH9 expression is required for embryonic development. In contrast, MYH9+/- mice were viable and fertile without gross anatomical, hematological, and nephrological abnormalities. Immunofluorescence analysis also showed the normal cytoplasmic distribution of NMMHCA. We further measured the auditory brainstem response and found two of six MYH9+/- mice had hearing losses, whereas the remaining four were comparable to wild-type mice. Such observation may parallel the diverse expression of Alport's manifestations of human individuals with MYH9 disorders and suggest the limited requirement of the gene for maintenance and function of specific organs. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1163 / 1171
页数:9
相关论文
共 34 条
[1]  
Arrondel C, 2002, J AM SOC NEPHROL, V13, P65, DOI 10.1681/ASN.V13165
[2]   Characterization of unconventional MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice [J].
Avraham, KB ;
Hasson, T ;
Sobe, T ;
Balsara, B ;
Testa, JR ;
Skvorak, AB ;
Morton, CC ;
Copeland, NG ;
Jenkins, NA .
HUMAN MOLECULAR GENETICS, 1997, 6 (08) :1225-1231
[3]   A millennial myosin census [J].
Berg, JS ;
Powell, BC ;
Cheney, RE .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (04) :780-794
[4]   Defects in cell adhesion and the visceral endoderm following ablation of nonmuscle myosin heavy chain II-A in mice [J].
Conti, MA ;
Even-Ram, S ;
Liu, CY ;
Yamada, KM ;
Adelstein, RS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) :41263-41266
[5]   Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes [J].
D'Apolito, M ;
Guarnieri, V ;
Boncristiano, M ;
Zelante, L ;
Savoia, A .
GENE, 2002, 286 (02) :215-222
[6]   Genetics, clinical and pathological features of glomerulonephrites associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) [J].
Ghiggeri, GM ;
Caridi, G ;
Magrini, U ;
Sessa, A ;
Savoia, A ;
Seri, M ;
Pecci, A ;
Romagnoli, R ;
Gangarossa, S ;
Noris, P ;
Sartore, S ;
Necchi, V ;
Ravazzolo, R ;
Balduini, CL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :95-104
[7]  
Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.3.CO
[8]  
2-6
[9]   A novel RFP-RET transgenic mouse model with abundant eumelanin in the cochlea [J].
Hayashi, H ;
Sone, M ;
Ito, S ;
Wakamatsu, K ;
Kato, M ;
Nakashima, I ;
Nakashima, T .
HEARING RESEARCH, 2004, 195 (1-2) :35-40
[10]   Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes [J].
Heath, KE ;
Campos-Barros, A ;
Toren, A ;
Rozenfeld-Granot, G ;
Carlsson, LE ;
Savige, J ;
Denison, JC ;
Gregory, MC ;
White, JG ;
Barker, DF ;
Greinacher, A ;
Epstein, CJ ;
Glucksman, MJ ;
Martignetti, JA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (05) :1033-1045